Reconsidering the turnaround times for BRAF V600 mutation analysis in non-small-cell lung cancer: a molecular diagnosis in one day is achievable for rapid treatment choices

A. Uguen

Abstract


-

Keywords


non-small cell lung carcinoma; BRAFV600E; immunohistochemistry; real-time PCR; dabrafenib plus trametinib therapy

Full Text:

PDF HTML


DOI: http://dx.doi.org/10.3747/co.26.4779






Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)